ConductScience.org, home

Paper17625614

Gene therapy trials for the treatment of high-grade gliomas.

Sonabend AM and 2 others. Gene Ther Mol Biol, 2007. Cited by 13 papers, by iCite.

Cite this record

ConductScience Library. Gene therapy trials for the treatment of high-grade gliomas. Papers, record 17625614. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17625614

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Gene therapy trials for the treatment of high-grade gliomas.
PubMed
Journal
Gene Ther Mol Biol
PubMed
Year
2007
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
0.32
iCite
Revised in PubMed
2025-05-29
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sonabend AMAdam M
2Ulasov IVIlya V
3Lesniak MSMaciej S

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
K08 NS046430NINDS NIH HHSUnited StatesK08NS046430PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References100

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17213145Epidemiologic study of primary intracranial neoplasms.Arch Neurol1981https://conductscience.org/library/papers/7213145PubMed
214682372Oncolytic viruses: clinical applications as vectors for the treatment of malignant gliomas.J Neurooncol2003https://conductscience.org/library/papers/14682372PubMed
314520660Imaging-guided convection-enhanced delivery and gene therapy of glioblastoma.Ann Neurol2003https://conductscience.org/library/papers/14520660PubMed
410350260Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens.J Neurosurg1999https://conductscience.org/library/papers/10350260PubMed
511960316The potential for efficacy of the modified (ICP 34.5(-)) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle study.Gene Ther2002https://conductscience.org/library/papers/11960316PubMed
610839262Dependence of efficient adenoviral gene delivery in malignant glioma cells on the expression levels of the Coxsackievirus and adenovirus receptor.J Neurosurg2000https://conductscience.org/library/papers/10839262PubMed
711304771Results of a pilot study involving the use of an antisense oligodeoxynucleotide directed against the insulin-like growth factor type I receptor in malignant astrocytomas.J Clin Oncol2001https://conductscience.org/library/papers/11304771PubMed
87767638Retroviruses as vectors.Br Med Bull1995https://conductscience.org/library/papers/7767638PubMed
912952282
Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of recurrent glioblastoma: preliminary observations in a patient with a favorable response to therapy.
J Neurooncol2003https://conductscience.org/library/papers/12952282PubMed
1016257582Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme.Mol Ther2006https://conductscience.org/library/papers/16257582PubMed
1115359291Experimental infections of humans with wild-type adenoviruses and with replication-competent adenovirus vectors: replication, safety, and transmission.Cancer Gene Ther2004https://conductscience.org/library/papers/15359291PubMed
1215449107Specific gene suppression using antisense strategy for growth suppression of glioma.Med Electron Microsc2004https://conductscience.org/library/papers/15449107PubMed
1312839017Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results.J Clin Oncol2003https://conductscience.org/library/papers/12839017PubMed
148384892Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir.Hum Gene Ther1993https://conductscience.org/library/papers/8384892PubMed
1511221866Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration.Cancer Res2001https://conductscience.org/library/papers/11221866PubMed
1615173839Targeted therapy for brain tumours.Nat Rev Drug Discov2004https://conductscience.org/library/papers/15173839PubMed
178289093Loss in expression of the retinoblastoma gene product in human gliomas is associated with advanced disease.J Neurooncol1993https://conductscience.org/library/papers/8289093PubMed
1812952304Neural stem cell biology may be well suited for improving brain tumor therapies.Cancer J2003https://conductscience.org/library/papers/12952304PubMed
1915509514AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: a randomised, controlled study.Mol Ther2004https://conductscience.org/library/papers/15509514PubMed
209812900Reovirus therapy of tumors with activated Ras pathway.Science1998https://conductscience.org/library/papers/9812900PubMed

See all 100 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
33776419The Current Status of Gene Therapy for the Treatment of Cancer.Biologics2021https://conductscience.org/library/papers/33776419PubMed
28251571Survivin a radiogenetic promoter for glioblastoma viral gene therapy independently from CArG motifs.Clin Transl Med2017https://conductscience.org/library/papers/28251571PubMed
26598957Overview of current immunotherapeutic strategies for glioma.Immunotherapy2015https://conductscience.org/library/papers/26598957PubMed
26056588Gene therapy for malignant glioma.Mol Cell Ther2014https://conductscience.org/library/papers/26056588PubMed
22049262NEURO-ONCOLOGIC PHYSICAL THERAPY FOR THE OLDER PERSON.Top Geriatr Rehabil2011https://conductscience.org/library/papers/22049262PubMed
20942909FasL and FADD delivery by a glioma-specific and cell cycle-dependent HSV-1 amplicon virus enhanced apoptosis in primary human brain tumors.Mol Cancer2010https://conductscience.org/library/papers/20942909PubMed
19860653Stem cells as delivery vehicles for oncolytic adenoviral virotherapy.Curr Gene Ther2009https://conductscience.org/library/papers/19860653PubMed
18649343Evaluation of E1A double mutant oncolytic adenovectors in anti-glioma gene therapy.J Med Virol2008https://conductscience.org/library/papers/18649343PubMed
18632631Low-dose radiation enhances survivin-mediated virotherapy against malignant glioma stem cells.Cancer Res2008https://conductscience.org/library/papers/18632631PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17625614

GET https://conductscience.org/api/papers/v1/17625614/references?page=2